EN1L
REGN icon

Engine No 1 LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Engine No 1 LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-724
Closed -$457K – 237
2021
Q4 		$457K Buy
724
+154
+27% +$94.7K 0.09% 133
2021
Q3 		$345K Buy
+570
New +$354K 0.09% 134

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engine No 1 LLC's REGN Position: Q1 2022 in Review

Engine No 1 LLC sold out of Regeneron Pharmaceuticals (REGN) in Q1 2022, closing a stake of 724 shares — an estimated $457K sold.

Engine No 1 LLC first reported a position in REGN in Q3 2021 and held it in 2 quarters. The position peaked at $457K in Q4 2021. 1,095 funds tracked by Wall St. Rank hold REGN as of Q1 2022.

  • Engine No 1 LLC reported no remaining Regeneron Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Engine No 1 LLC sold 724 Regeneron Pharmaceuticals shares in Q1 2022, an estimated $457K.
  • Engine No 1 LLC first reported a position in Regeneron Pharmaceuticals in Q3 2021 and held it in 2 quarters.
  • Engine No 1 LLC's Regeneron Pharmaceuticals position peaked at $457K in Q4 2021.
  • 1,095 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2022.

Based on Engine No 1 LLC's 13F filing for Q1 2022, filed 13 May 2022.